Does use of tetracyclic antidepressant-mirtazapine reduce cancer risk in depression patients?

Author:

Sun Li-Min1,Lin Ming-Chia2,Liang Ji-An34,Chang Yen-Jung5,Chang Shih-Ni5,Sung Fung-Chang56,Muo Chih-Hsin5,Kao Chia-Hung47

Affiliation:

1. Department of Radiation Oncology; Zuoying Branch of Kaohsiung Armed Forces General Hospital; Kaohsiung Taiwan

2. Department of Nuclear Medicine; E-DA Hospital; Kaohsiung Taiwan

3. Department of Radiation Oncology; China Medical University Hospital; Taichung Taiwan

4. Graduate Institute of Clinical Medicine Science and School of Medicine, College of Medicine; China Medical University; Taichung Taiwan

5. Management Office for Health Data; China Medical University Hospital; Taichung Taiwan

6. Department of Public Health; China Medical University; Taichung Taiwan

7. Department of Nuclear Medicine PET Center; China Medical University Hospital; Taichung Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference47 articles.

1. Population pharmacokinetic analysis of mirtazapine;Grasmader;Eur J Clin Pharmacol,2004

2. Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care;Pirraglia;Prim Care,2003

3. Mirtazapine: clinical overview;Gorman;J Clin Psychiatry,1999

4. Review of the use of mirtazapine in the treatment of depression;Benjamin;Expert Opin Pharmaco,2011

5. A review of the pharmacological and clinical profile of mirtazapine;Anttila;CNS Drug Rev,2001

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3